These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 17550891)

  • 41. Activity of ertapenem and other antimicrobials against ESBL-producing enterobacteria isolated from urine in patients from Madrid.
    Tamayo J; Orden B; Cacho J; Cuadros J; Gomez-Garces JL; Alos JI
    Rev Esp Quimioter; 2007 Sep; 20(3):334-8. PubMed ID: 18080031
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Raoultella ornithinolytica in urinary tract infections. Clinical and microbiological study of a series of 4 oncologic patients].
    García-Lozano T; Pascual Plá FJ; Aznar Oroval E
    Med Clin (Barc); 2013 Aug; 141(3):138-9. PubMed ID: 23332629
    [No Abstract]   [Full Text] [Related]  

  • 43. Extended-spectrum beta-lactamases in long-term-care facilities.
    Nicolas-Chanoine MH; Jarlier V;
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():111-6. PubMed ID: 18154534
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Incidence of resistance transfer factor (R factor) among enterobacteriaceae in urinary tract infections.
    Panse MV; Wadhwa KM
    Indian J Med Res; 1973 Nov; 61(11):1594-9. PubMed ID: 4791505
    [No Abstract]   [Full Text] [Related]  

  • 45. Double-gradient plate susceptibility testing of an Enterococcus and its L-form.
    Dietz CC; Metzger JB; Smith MA
    Am J Med Technol; 1973 Feb; 39(2):55-9. PubMed ID: 4701052
    [No Abstract]   [Full Text] [Related]  

  • 46. Activity of temocillin against KPC-producing Enterobacteriaceae clinical isolates.
    Tsakris A; Koumaki V; Politi L; Balakrishnan I
    Int J Antimicrob Agents; 2020 Jan; 55(1):105843. PubMed ID: 31715258
    [No Abstract]   [Full Text] [Related]  

  • 47. Drug resistance of pathogenic enterobacteriae in Indonesian children.
    Suharjono ; Alamsjah E; Asnil PO; Sunoto ; Tumbelaka WA
    Paediatr Indones; 1977; 17(1-2):11-7. PubMed ID: 327399
    [No Abstract]   [Full Text] [Related]  

  • 48. In vitro resistance of a 4-quinolone after two years of clinical use.
    Drlicek M; Grisold W; Armbruster C; Vetter N
    J Chemother; 1989 Jul; 1(4 Suppl):378-9. PubMed ID: 16312448
    [No Abstract]   [Full Text] [Related]  

  • 49. [Studies with temocillin].
    Crusius S
    Z Gesamte Hyg; 1989 Jul; 35(7):403-6. PubMed ID: 2800645
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative in vitro activity of temocillin against clinical isolates of Enterobacteriaceae.
    Van Noyen R; Ursi JP; Rummens JL; Hubrechts JM; Drion S; Colaert J; Bellon A; Beert J
    Acta Clin Belg; 1988; 43(6):449-51. PubMed ID: 3239347
    [No Abstract]   [Full Text] [Related]  

  • 51. Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline.
    Garau J
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():198-202. PubMed ID: 18154548
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Breakpoints for extended-spectrum beta-lactamase-producing Enterobacteriacae: pharmacokinetic/pharmacodynamic considerations.
    MacGowan A
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():166-8. PubMed ID: 18154541
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Selection of antibodies for the treatment of biliary tract infections].
    Kalemba M; Kluczyński S; Nowicka B
    Wiad Lek; 1981 Mar; 34(6):471-4. PubMed ID: 7023069
    [No Abstract]   [Full Text] [Related]  

  • 54. High resistance to fourth-generation cephalosporins among clinical isolates of Enterobacteriaceae producing extended-spectrum beta-lactamases isolated in Portugal.
    Fernandes R; Gestoso A; Freitas JM; Santos P; Prudêncio C
    Int J Antimicrob Agents; 2009 Feb; 33(2):184-5. PubMed ID: 18926667
    [No Abstract]   [Full Text] [Related]  

  • 55. Infections with Providence bacilli. A clinical and bacteriologic study.
    Solberg CO; Matsen JM
    Am J Med; 1971 Feb; 50(2):241-6. PubMed ID: 5545459
    [No Abstract]   [Full Text] [Related]  

  • 56. [Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae].
    Nordmann P
    Pathol Biol (Paris); 2006 Feb; 54(1):7-9. PubMed ID: 16376173
    [No Abstract]   [Full Text] [Related]  

  • 57. Relationship between susceptibility to antimicrobials and virulence factors in paediatric Escherichia coli isolates.
    Arisoy M; Rad AY; Akin A; Akar N
    Int J Antimicrob Agents; 2008 Feb; 31 Suppl 1():S4-8. PubMed ID: 17959360
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Urinary tract infections in the elderly: hemagglutinating properties and susceptibility to antibacterial agents of the uropathogenic strains].
    Padilla C; Brevis P; Padilla R; Ortega P; Fernández M; Rabie S
    Rev Med Chil; 1988 Mar; 116(3):222-8. PubMed ID: 3244929
    [No Abstract]   [Full Text] [Related]  

  • 59. [ESBL--increasing resistance problems. Cephalosporins no longer obvious choice in diffuse infections].
    Hallgren H; Gustafsson I; Ripa T
    Lakartidningen; 2007 Dec; 104(51-52):3883-5. PubMed ID: 18232531
    [No Abstract]   [Full Text] [Related]  

  • 60. [Estimation of the contribution of the small plasmids in creation of ESBL phenotype among clinical and ambulatory isolates of the Enterobacteriaceae].
    Nieradko J
    Med Dosw Mikrobiol; 2007; 59(3):223-30. PubMed ID: 18078117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.